BiotechTube

Micafungin + Caspofungin

Phase 3Completed
1 views this week 0 watching⚡ Active
Interest: 40/100
40
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Candidiasis

Conditions

Candidiasis, Candidemia

Trial Timeline

Sep 1, 2004 → Apr 1, 2006

NCT ID
NCT00105144

About Micafungin + Caspofungin

Micafungin + Caspofungin is a phase 3 stage product being developed by Astellas Pharma for Candidiasis. The current trial status is completed. This product is registered under clinical trial identifier NCT00105144. Target conditions include Candidiasis, Candidemia.

What happened to similar drugs?

5 of 20 similar drugs in Candidiasis were approved

Approved (5) Terminated (4) Active (12)
✅Fluconazole + MicafunginAstellas PharmaApproved
✅Caspofungin + Normal SalineMerckApproved
✅VoriconazolePfizerApproved
✅Eraxis (anidulafungin) + Diflucan (fluconazole) + Vfend (voriconazole)PfizerApproved
✅Clotrimazole vaginal tablet + FluconazoleBayerApproved
🔄Isavuconazole + Caspofungin + VoriconazoleAstellas PharmaPhase 3
🔄Micafungin + fluconazoleAstellas PharmaPhase 3

Hype Score Breakdown

Clinical
17
Activity
8
Company
15
Novelty
0
Community
0

Clinical Trials (2)

NCT IDPhaseStatus
NCT00105144Phase 3Completed
NCT00665639Phase 3Completed

Competing Products

20 competing products in Candidiasis

See all competitors
ProductCompanyStageHype Score
MicafunginAstellas PharmaPhase 1
29
Isavuconazole + Caspofungin + VoriconazoleAstellas PharmaPhase 3
40
Micafungin + fluconazoleAstellas PharmaPhase 3
40
Micafungin (Mycamine)Astellas PharmaPhase 1
29
Fluconazole + MicafunginAstellas PharmaApproved
35
Micafungin + FluconazoleAstellas PharmaPhase 3
40
MicafunginAstellas PharmaPhase 2
35
micafungin + caspofunginAstellas PharmaPhase 3
40
micafungin + amphotericin B deoxycholateAstellas PharmaPhase 3
32
FK463Astellas PharmaPhase 2
35
Micafungin + Liposomal Amphotericin BAstellas PharmaPhase 3
40
SHR8008 + FluconazoleJiangsu Hengrui MedicinePhase 3
36
SHR8008 capsule + Fluconazole capsuleJiangsu Hengrui MedicinePhase 3
36
L-743,872MerckPre-clinical
26
CaspofunginMerckPhase 2
35
L-743,872MerckPhase 2
27
Caspofungin + Amphotericin B DeoxycholateMerckPhase 2
27
Caspofungin acetate + PlaceboMerckPhase 2
27
Caspofungin + Normal SalineMerckApproved
43
caspofungin acetateMerckPhase 3
40